Hydrolytic Lysosomal N-terminal Tripeptidyl Peptidase
This page covers all Hydrolytic Lysosomal N-terminal Tripeptidyl Peptidase drugs tracked by Drug Landscape: marketed products and active clinical-stage compounds.
Marketed (1)
- Rhttp1 · BioMarin · Neuroscience
Cerliponase alfa works by inhibiting the breakdown of a protein called tripeptidyl peptidase, which is deficient in patients with late-infantile neuronal ceroid lipofuscinosis.
Patent intelligence
- hydrolytic lysosomal n terminal tripeptidyl peptidase patent landscape — aggregated cliff calendar, attackable patents, originator estates